Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 171-180 of 579 for sleep

Edit search filters
  1. Placebo Controlled Study of VS-6063 in Subjects with Malignant Pleural Mesothelioma

    Rochester, MN

  2. Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone

    Rochester, MN

  3. Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung

    Rochester, MN

  4. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

    Rochester, MN

  5. Evaluation of the Spiration Valve for Emphysema to Improve Lung Function

    Jacksonville, FL

  6. A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis

    Rochester, MN

  7. Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

    Rochester, MN

  8. Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma

    Rochester, MN

  9. The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach

    Rochester, MN

  10. A Study of a Multicomponent Intervention Aimed at Decreasing Perception of Dyspnea in Participants with Lung Disease Who are Obese

    Rochester, MN

.

Mayo Clinic Footer